BioCentury
ARTICLE | Financial News

Cel-Sci raises $1.5M in direct public offering

May 4, 2017 4:07 PM UTC

On May 1, cancer and infectious disease company Cel-Sci Corp. (NYSE-M:CVM) raised $1.5 million through the sale of 13.2 million shares at $0.115 in a registered direct offering with an institutional ...

BCIQ Company Profiles

Cel-Sci Corp.